Oscar Health, Inc. (NYSE:OSCR) Receives Average Rating of “Hold” from Brokerages

Oscar Health, Inc. (NYSE:OSCR) has been assigned a consensus recommendation of “Hold” from the nine ratings firms that are currently covering the firm, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, two have given a hold recommendation, four have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $21.56.

A number of equities analysts have recently commented on OSCR shares. Jefferies Financial Group began coverage on Oscar Health in a report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 price target for the company. Bank of America downgraded Oscar Health from a “neutral” rating to an “underperform” rating and cut their target price for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th.

Oscar Health Trading Up 3.2 %

NYSE:OSCR opened at $15.77 on Thursday. The firm’s 50 day moving average is $15.18 and its 200 day moving average is $16.84. Oscar Health has a 12 month low of $13.05 and a 12 month high of $23.79. The stock has a market capitalization of $3.90 billion, a PE ratio of -262.71, a price-to-earnings-growth ratio of 0.67 and a beta of 1.73. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. Sell-side analysts expect that Oscar Health will post -0.01 earnings per share for the current year.

Insider Transactions at Oscar Health

In other news, Vice Chairman Joshua Kushner acquired 276,040 shares of Oscar Health stock in a transaction dated Monday, November 11th. The shares were purchased at an average cost of $13.58 per share, for a total transaction of $3,748,623.20. Following the transaction, the insider now owns 5,031,262 shares of the company’s stock, valued at $68,324,537.96. This trade represents a 5.80 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CAO Victoria Baltrus sold 8,078 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $146,050.24. Following the completion of the sale, the chief accounting officer now owns 146,036 shares of the company’s stock, valued at $2,640,330.88. The trade was a 5.24 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders acquired 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. 25.11% of the stock is owned by insiders.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Lingotto Investment Management LLP bought a new position in shares of Oscar Health during the 4th quarter valued at $2,543,000. Handelsbanken Fonder AB boosted its position in Oscar Health by 148.3% during the fourth quarter. Handelsbanken Fonder AB now owns 29,800 shares of the company’s stock valued at $401,000 after buying an additional 17,800 shares during the period. Ieq Capital LLC bought a new position in shares of Oscar Health during the fourth quarter valued at about $203,000. Alberta Investment Management Corp purchased a new position in shares of Oscar Health in the fourth quarter worth about $138,000. Finally, State of New Jersey Common Pension Fund D lifted its stake in shares of Oscar Health by 6.4% in the 4th quarter. State of New Jersey Common Pension Fund D now owns 116,555 shares of the company’s stock valued at $1,566,000 after acquiring an additional 6,965 shares during the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.